Medical News Today: Investigational drug shows promise for hard-to-treat renal cancer
Savolitinib seems to halt tumor progression in some people with papillary renal cell carcinoma - a form of kidney cancer - according to new study results.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Health | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology